
 |
| 2004 Parts B and C Grant Award Application Packages
(Dec 04, 2003)
|
| 2004 Parts B and C Grant Award Application Packages for IDEA. |
 |
| 2005 Parts B and C Grant Award Application Packages
(Mar 02, 2005)
|
| 2005 Parts B and C Grant Award Application Packages for IDEA. |
 |
| Americans with Disabilities Act (ADA)
(Jul 25, 2000)
|
| The Americans with Disabilities Act (ADA) gives civil rights protections to individuals with disabilities that are like those provided to individuals on the basis of race, sex, national origin, and religion. |
 |
| Annual State Application Under Part B Of the Individuals With Disabiliteis Education Act for Federal Fiscal Year 2004 (CFDA Nos. 84.027 and 84.173)
(Dec 04, 2003)
|
| Cover Page and Application Parts I and II to apply for Funds Under Part B of IDEA FFY 2004. |
 |
| Annual State Application Under Part B Of the Individuals With Disabiliteis Education Act for Federal Fiscal Year 2005 (CFDA Nos. 84.027 and 84.173) (MS Word)
(Mar 02, 2005)
|
| Cover Page and Application Parts I and II to apply for Funds Under Part B of IDEA FFY 2005. |
 |
| Annual State Application Under Part B of the Individuals with Disabilities Education Act (MS Word)
(Mar 02, 2005)
|
| Submission Statement for Part B in IDEA |
 |
| Annual State Application Under Part C of the Individuals with Disabilities Education Act (MS Word)
(Mar 02, 2005)
|
| Submission Statement for Part C in IDEA |
 |
| Appendix B: EDGAR 34 CFR 76.703; When A State May Begin To Obligate Funds
(Dec 03, 2003)
|
| Timing of Grant allocation According to the Education Department General Administrative Regulations (EDGAR). Appendix B. |
 |
| Certifications Regarding Lobbying; debarment, Suspension And Other responsibility Matters; Drug-Free Workplace Requirements
(Dec 04, 2003)
|
| Outlines the guidelines for lobbying and requirements grantees to maintain a drug-free workplace. |
 |
| Certifications Regarding Lobbying; debarment, Suspension And Other responsibility Matters; Drug-Free Workplace Requirements (MS Word)
(Mar 02, 2005)
|
| Outlines the guidelines for lobbying and requirements grantees to maintain a drug-free workplace. |
 |